Whole-genome sequencing, which looks at a bigger genetic picture than targeted gene panels, is offering new hope for the 3% of infants born with rare genetic diseases; there are a growing number of patients taking specialty drugs being hit with sticker shock as they find their expensive medications are no longer shielded by co-pay assistance programs; veterans groups are praising the nomination of Robert Wilkie to lead the Department of Veterans Affairs (VA) as a stabilizing next step for the troubled agency.
Whole-genome sequencing, which looks at a bigger genetic picture than targeted gene panels, is offering new hope for the 3% of infants born with rare genetic diseases, The Wall Street Journal reported. Neonatal physicians may be able to make diagnoses that once took weeks or months, often at great expense, in a matter of days, allowing for treatment to begin sooner.There are a growing number of patients taking specialty drugs being hit with sticker shock as they find their expensive medications are no longer shielded by co-pay assistance programs that help cover their costs, Kaiser Health News reported. Kaiser profiled a woman whose multiple sclerosis drug cost $90,000 and the change means that the pharmaceutical company’s co-pay assistance no longer counts towards her $8800 pharmacy deductible. In these programs, consumers typically owe nothing or have modest monthly co-payments for pricey drugs because many manufacturers pay a patient’s portion of the cost to the insurer.
Veterans groups are praising the nomination of Robert Wilkie to lead the Department of Veterans Affairs (VA) as a stabilizing next step for the troubled agency, The Hill reported. Wilkie, who is serving as acting VA secretary, is drawing bipartisan praise. He has years of Capitol Hill and Pentagon experience, has worked for 2 presidents, and has drawn praise from both Republicans and Democrats. The nomination is seen as a safe choice in the aftermath of the failed nomination of former White House physician Ronny Jackson.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More